Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Unknown 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Genitourinary 1

Conditions

Prostatic Neoplasms 690Urinary Bladder Neoplasms 250Carcinoma, Renal Cell 188Kidney Neoplasms 94Neoplasms 72Carcinoma, Transitional Cell 68Breast Neoplasms 65Lung Neoplasms 37Ovarian Neoplasms 36Melanoma 36Stomach Neoplasms 35Non-Muscle Invasive Bladder Neoplasms 35Colorectal Neoplasms 35Neoplasm Metastasis 33Pancreatic Neoplasms 30Carcinoma, Non-Small-Cell Lung 28Recurrence 26Colonic Neoplasms 24Urologic Neoplasms 20Testicular Neoplasms 20Uterine Cervical Neoplasms 19Esophageal Neoplasms 19Head and Neck Neoplasms 18Disease 18Wilms Tumor 17Carcinoma, Hepatocellular 17Liver Neoplasms 16Prostatic Hyperplasia 15Endometrial Neoplasms 15Sarcoma 14

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Unknown × Pseudomonas Infections × Genitourinary × Clear all
NCT05975151 2023-09-21

Efficacy and Safety of Pseudomonas Aeruginosa for Intermediate and High-risk Non-muscle Invasive Bladder Cancer

Qilu Hospital of Shandong University

Phase 2 Unknown
63 enrolled
Genitourinary

Non-Muscle Invasive Bladder Neoplasms, Urinary Bladder Neoplasms, Pseudomonas Infections

Data powered by HemOnc (CC BY 4.0) Colophon âš¡